Esperion Therapeutics
ESPR
#8328
Rank
A$0.26 B
Marketcap
$1.33
Share price
-10.32%
Change (1 day)
-55.31%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -$4.23

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.40. In 2022 the company made an earnings per share (EPS) of -$5.53 an increase over its 2021 EPS that were of -$14.90.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.23-23.54%
2022-$5.53-62.87%
2021-$14.9080.38%
2020-$8.2650.14%
2019-$5.50-53.18%
2018-$11.757.41%
2017-$10.94110.81%
2016-$5.1947.35%
2015-$3.520.89%
2014-$3.4928.84%
2013-$2.71-89.3%
2012-$25.34
2002-$10.678.89%
2001-$9.80-83.77%
2000-$60.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$15.96 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.21-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.90-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$58.24-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.00-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.06-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA